About Cala Health
Cala Health is a bioelectronic medicine company that develops FDA-cleared, wearable neuromodulation therapies for chronic diseases. Its flagship Cala kIQ System uses TAPS (transcutaneous afferent patterned stimulation) therapy to deliver non-invasive, individualized peripheral nerve stimulation for the relief of action hand tremors in essential tremor and Parkinson's disease patients. The company, a spinout from Stanford Biodesign, is expanding its pipeline into neurology, cardiology, and psychiatry.
Company details
Funding
Total raised
$263M
Last stage
Growth
Investors
Founders
Scott Delp
James H. Clark Professor of Bioengineering, Mechanical Engineering, and Orthopaedic Surgery at Stanford University and Founding Chairman of Stanford's Department of Bioengineering. Has co-founded six health technology companies.
LinkedInKate Rosenbluth
Stanford Biodesign Innovation Fellow who co-founded Cala Health after discovering that deep brain stimulation targets were accessible via peripheral nerves in the wrist. Teamed with Scott Delp to launch the company.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.